Researchers at Washington University School of Medicine in St. Louis have been awarded $7.5 million from the National Institutes of Health (NIH) to investigate a form of dementia caused by cerebral small vessel disease, the second-leading cause of dementia after Alzheimer’s disease.
Chiesi champions new inhaler propellant to reduce carbon footprint
Share this article Chiesi hopes to lower Scope 3 emissions by changing the propellant used in its inhalers, said Harriet Lewis, director of market access